Product
VRC01LS
Aliases
VRC-HIVMAB080-00-AB
3 clinical trials
2 indications
Indication
HIV InfectionsIndication
HIV InfectionClinical trial
A Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC-HIVMAB060-00-AB (VRC01) and VRC-HIVMAB080-00-AB (VRC01LS) in the Serum and Mucosa of Healthy, HIV-Uninfected Adult ParticipantsStatus: Completed, Estimated PCD: 2019-06-05
Clinical trial
Open-Label, Dose-Escalating, Phase I Study to Determine Safety and Pharmacokinetic Parameters of Subcutaneous (SC) VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed InfantsStatus: Completed, Estimated PCD: 2020-06-17
Clinical trial
A Clinical Trial to Evaluate the Impact of Broadly Neutralizing Antibodies VRC01LS and 10-1074 on Maintenance of HIV Suppression in a Cohort of Early-Treated Children in Botswana (Dual bNAb Treatment in Children)Status: Completed, Estimated PCD: 2021-12-03